• <strike id="xmwty"><table id="xmwty"></table></strike>
    <progress id="xmwty"></progress>

      <b id="xmwty"></b>

      ×

      Global Expansion | Tonghua Dongbao's Mixed Isophane Protamine Human Insulin Injection (30R) Approved for Marketing in Uzbekistan

      Date:2025-03-23
      Author:東寶
      Views:2

      Tonghua Dongbao Pharmaceutical Co., Ltd. ("the Company") recently received marketing approval for its Mixed Isophane Protamine Human Insulin Injection (30R) from the regulatory authorities of Uzbekistan. This approval marks the Company's official entry into the Uzbek market for human insulin injections and is expected to further expand its overseas sales potential.

       

      Located in Central Asia, Uzbekistan is a key emerging market participating in the Belt and Road Initiative, with a large population and growing healthcare needs. As of October 2024, Uzbekistan had a total population of approximately 37.36 million. According to the 10th edition of the International Diabetes Federation (IDF) Global Diabetes Atlas (2021), there were about 1.3518 million diabetes patients aged 20 to 79 in Uzbekistan, with a prevalence rate of 6.3%. Among these, undiagnosed cases accounted for a high proportion, reaching 74%.

       

      To seize overseas opportunities, the Company has leveraged its competitive strengths and implemented a differentiated expansion strategy, tailored to the market size, growth potential, healthcare system, medication needs, and treatment habits of each target country or region. Its human insulin products are primarily positioned for emerging markets and developing countries in the Belt and Road Initiative, with customized sales strategies based on local conditions.

       

      As the Marketing Authorization Holder (MAH), the Company received the marketing license for Mixed Isophane Protamine Human Insulin Injection (30R) from the Ministry of Health of the Republic of Uzbekistan. This approval enriches the Company's international product portfolio, enhances its brand presence, expands its global business, and provides a replicable pathway for future overseas regulatory approvals. It is expected to accelerate the Company's expansion in emerging markets and Belt and Road countries and strengthen its competitiveness in the international market.


      0 国产在线看片av免费,91中文字幕 国产,国产丝袜脚足j在线视频播放,黄视频在线观看无码免费
    1. <strike id="xmwty"><table id="xmwty"></table></strike>
      <progress id="xmwty"></progress>

        <b id="xmwty"></b>

        黄片观看一区二区三区| 久久精品在这里色伊人| AV剧情麻豆映画国产在线观看| 日韩黄色一级片| 老女乱中文字幕熟女熟妇| 亚洲人碰在线视频| 日韩欧美在线播放| 日韩亚洲性爱无码视频| 欧美激情一区二区亚洲专区| 国产日韩欧美一区二区| 精品动漫无码一区二| 国产一级黄片免费观看视频| 最新AV在线播放免费不卡| 老司机精品人妻久久| 亚洲永久中文字幕在线| 久久久久久久综合综合狠狠| 国产毛片精品国产一区二区三区| 亚洲精品无码高潮喷水A| 在线播放中文字幕无码免费| 国产免费丝袜精品无码视频| 久久精品国产国产精| 亚洲欧美综合人成在线| 亚洲国产成人资源在线| 国产在视频精品视频| 亚洲高清在线| av无码福利一区二区三区| 亚洲中文字乱码免费播放| 黄床大片免费30分钟国产精品| 制服丝袜中文无码人妻97|